The Effect of Back Muscles Activation on Idiopathic Scoliosis Using Surface Electromyography

April 18, 2024 updated by: Ju Seok Ryu, Seoul National University Hospital
The purpose of this study is to evaluate the effect of back muscle activations on idiopathic scoliosis

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  • Design: Prospective study
  • Setting: hospital rehabilitation department
  • Intervention: Participants were asked to walk with a surface electromyography(EMG) attached to their back muscles. After repeating the same process with different leg lengths discrepancy (0cm, 0.5cm, 1cm), participants are compared the main outcome measures.
  • Main outcome measures: surface electromyography(EMG)

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
    • Gyeonggi-do
      • Seongnam, Gyeonggi-do, Korea, Republic of, 463-707
        • Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy children (5 to 12 years old)

Exclusion Criteria:

  • Children with leg length discrepancy over 0.5cm
  • Children complaining of acute low back pain
  • Children with spinal scoliosis
  • Children with cerebral palsy, muscle paralysis, polio, congenital spinal abnormalities
  • Children who underwent spinal surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy children (5 to 12 years old)
Behavioral: gait with leg length discrepancy
After attaching the surface electromyography(EMG) to bilateral back muscles, participants walk at a comfortable speed. The investigators will evaluate the effects of leg length discrepancy on the back muscle activation during gait.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surface electromyography
Time Frame: 20 minutes

surface muscle contraction of bilateral back muscles

  • bilateral spinal muscles on T6, T12, L3
  • bilateral quadratus lumborum muscles
  • bilateral iliopsoas muscles
20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Seoul National University Hospital

Investigators

  • Study Director: Jusuk Ryu, M.D. PhD, Seoul National University Bundang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2022

Primary Completion (Actual)

February 28, 2023

Study Completion (Actual)

December 12, 2023

Study Registration Dates

First Submitted

April 12, 2022

First Submitted That Met QC Criteria

April 12, 2022

First Posted (Actual)

April 19, 2022

Study Record Updates

Last Update Posted (Actual)

April 19, 2024

Last Update Submitted That Met QC Criteria

April 18, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B-2203-747-302

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe